Informations:
Erreur:
ID
37396
Description
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02455076
Lien
https://clinicaltrials.gov/show/NCT02455076
Mots-clés
Versions (1)
- 22/07/2019 22/07/2019 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
22 juillet 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Type 2 Diabetes NCT02455076
Eligibility Type 2 Diabetes NCT02455076
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT02455076
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Age
Item
1. age < 18 or > 80 years
boolean
C0001779 (UMLS CUI [1])
Kidney Disease Unstable | Kidney Disease Rapidly progressive | Renal Insufficiency Severe | Creatinine clearance measurement
Item
9. patients with unstable or rapidly progressing renal disease or severe renal impairment (creatinine clearance < 30 ml/min)
boolean
C0022658 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2,1])
C1838681 (UMLS CUI [2,2])
C1565489 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0373595 (UMLS CUI [4])
C0443343 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2,1])
C1838681 (UMLS CUI [2,2])
C1565489 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0373595 (UMLS CUI [4])
Liver disease | Liver Cirrhosis | Icterus | End Stage Liver Disease
Item
10. patients with clinically significant hepatic disease (cirrhosis, jaundice, end-stage liver disease),
boolean
C0023895 (UMLS CUI [1])
C0023890 (UMLS CUI [2])
C0022346 (UMLS CUI [3])
C0745744 (UMLS CUI [4])
C0023890 (UMLS CUI [2])
C0022346 (UMLS CUI [3])
C0745744 (UMLS CUI [4])
Hypersensitivity Exenatide
Item
11. history of hypersensitivity to exenatide
boolean
C0020517 (UMLS CUI [1,1])
C0167117 (UMLS CUI [1,2])
C0167117 (UMLS CUI [1,2])
Heavy alcohol use Drinks per day | Gender | Drug abuse
Item
13. patients with history of heavy alcohol use (female > 2 drinks per day, male > 3 drinks per day) or drug abuse within 3 months prior to admission.
boolean
C0687132 (UMLS CUI [1,1])
C0001967 (UMLS CUI [1,2])
C0439505 (UMLS CUI [1,3])
C0079399 (UMLS CUI [2])
C0013146 (UMLS CUI [3])
C0001967 (UMLS CUI [1,2])
C0439505 (UMLS CUI [1,3])
C0079399 (UMLS CUI [2])
C0013146 (UMLS CUI [3])
Mental handicap | Study Protocol Comprehension Unable
Item
14. mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.
boolean
C1306341 (UMLS CUI [1])
C2348563 (UMLS CUI [2,1])
C0162340 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C2348563 (UMLS CUI [2,1])
C0162340 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
15. female subjects who are pregnant or breast feeding at time of enrollment into the study.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])